focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (2.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.00
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Next Gen Embedded Product Strategy for Auto DMS

2 Sep 2020 09:00

RNS Number : 7976X
Seeing Machines Limited
02 September 2020
 

Seeing Machines Limited

 

2 September 2020

 

Seeing Machines Announces Next Gen Embedded Product Strategy for Automotive DMS Market

 

Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, is pleased to announce its next generation 'Embedded Product Strategy' for the automotive market.

 

Highlights summary

· New "three pillar" strategy targets rapidly expanding camera-based interior monitoring market:

o First pillar: FOVIO Chip, newly advanced with the introduction of Seeing Machines' OcculaTM Neural Processing Unit

o Second pillar: A low-friction integration pathway into any vehicle integration point, including smart-mirrors, instrument clusters, infotainment ECUs or centralized ADAS processing systems

o Third pillar: OcculaTM is now available for license, in ASIC form, to world-leading semiconductor companies for integration with any automotive compute platform.

 

Representing a step-change in its delivery of Driver Monitoring System (DMS) technology to automotive Tier 1 suppliers and OEMs, Seeing Machines has unveiled an expanded strategy and product portfolio incorporating its next generation embedded processing pipeline technology. The enhanced "three pillar" offering targets the rapidly expanding camera-based interior monitoring market, extending cost, scalability and integration benefits for carmakers as well as safety and convenience for their customers.

 

Seeing Machines continues to grow as an automotive leader in DMS technology, now in tie-ups with six OEMs globally, across nine ongoing programs over an expanding range of vehicle models. The Seeing Machines FOVIO Chip (delivered in partnership with Xilinx) remains the highest performing, lowest cost market solution for standalone DMS vehicle integration and now represents nearly one-third of Seeing Machines booked business, and is projected to grow to approximately one half in response to Euro NCAP requirements. 

 

OEMs today are faced with a maze of electronics, software and sensor integration options for interior monitoring systems. Coupled with market dynamics such as regulation and Euro NCAP requirements for safety (which are now driving rapid adoption and mass market penetration), the Embedded Product Strategy has been designed to support a very wide range of common integration, cost, and safety performance challenges, with the flexibility to support the unexpected.

 

The first pillar of the Seeing Machines strategy remains the FOVIO Chip. However, the performance of the device is newly enhanced with the introduction of Seeing Machines' OcculaTM Neural Processing Unit ("OcculaTM"):

 

· OcculaTM is a custom processing design that accelerates Seeing Machines' unique algorithmic approach to the problem of human detection and tracking, placing the Company's technology at the "deep edge"

 

· OcculaTM delivers a breakthrough in silicon utilization when executing Seeing Machines' highly mature driver monitoring algorithms, reducing the computational load of the FOVIO chip by over 50% while delivering the same functionality and signal performance

 

· OcculaTM adds general-purpose acceleration capabilities required for future AI-based computer vision needs. Seeing Machines' customers will also be delighted to know that, since the FOVIO Chip utilizes FPGA technology, OcculaTM is a fully field upgradable offering

 

· OcculaTM makes way for new driver and interior monitoring features on existing FOVIO chips, further extending Seeing Machines' feature, performance, and cost leadership.

 

The second pillar of the embedded product strategy offers a low-friction integration pathway for the Company's driver and interior monitoring technology into any vehicle integration point, including smart-mirrors, instrument clusters, infotainment ECUs or centralized ADAS processing systems:

 

· This pathway is efficiently enabled via the introduction of Seeing Machines' embedded Driver Monitoring Engine (e-DME). The e-DME is the Company's core driver monitoring algorithm stack supporting both accelerated and non-accelerated compute options, over a very wide range of popular automotive compute platforms

 

· The e-DME includes versions which are deeply optimized and embedded for key automotive SoC platforms, leveraging the different state-of-the-art AI vision acceleration architectures in those devices.

 

As a third strategic pillar, OcculaTM is now available for license, in ASIC form, to world-leading semiconductor companies for integration with any automotive compute platform that would benefit from world leading, highly optimized, "deep edge" driver and/or interior monitoring.

 

Paul McGlone, CEO of Seeing Machines commented: "It's an exciting time in the Automotive industry and I'm delighted to be announcing our detailed technology strategy, which has been constructed to closely support OEMs as they design cars to meet mounting safety standards and deliver convenience features for their customers.

 

"Seeing Machines has been leading this market for many years now and our three pillar approach is no accident. We have leveraged our teams' years of experience, deep knowledge of industry requirements, and close customer relationships to support the many and varied requirements for DMS integration into cars as demand continues to accelerate around the world."

 

 

Enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - Corporate Communications

Cenkos Securities plc (Nominated Adviser and Broker)

Neil McDonald

Pete Lynch

+44 131 220 6939

Stifel Nicolaus Europe Limited (Joint Broker)

+44 20 7710 7600

Alex Price

Nick Adams

 

The person responsible for arranging the release of this announcement on behalf of Seeing Machines is Sophie Nicoll, Corporate Communications.

 

 

About Seeing Machines (LSE: SEE)

Seeing Machines Ltd., is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation.

Founded in 2000 and headquartered in Australia, the Company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical. www.seeingmachines.com

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAGRGDCRBGDGGD
Date   Source Headline
17th Mar 20107:05 amRNSSignificant DSS deal with BHP Billiton
15th Mar 20108:22 amRNSMajor DSS Contract Win
12th Feb 20107:00 amRNSSEEING MACHINES SIGNS MAJOR DEAL
5th Feb 20104:09 pmRNSQuarterly Newsletter
26th Nov 20099:15 amRNSResult of AGM
6th Nov 20097:00 amRNSChange of Chairman
26th Oct 20098:25 amRNSTrueField Analyzer
23rd Sep 20097:00 amRNSAnnual Financial Report
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.